4
Changes in Ownership
RESMED INC Filed Acc 0001127602-23-024408
Chief Executive Officer sold 5,675 shares at $146.35 ($830,514)
- Chief Executive Officer acquired 5,675 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2023-09-15 | Option exercise 10b5-1 | +5,675 | $57.76 | $327,788 | 455,035 | D |
| Farrell Michael J. Chief Executive Officer | 2023-09-15 | Sale 10b5-1 | −5,675 | $146.35 | $830,514 | 449,360 | D |
| Derivatives | |||||||
| Farrell Michael J. Chief Executive Officer | 2023-09-15 | Option exercise · ResMed Common Stock Options 10b5-1 | −5,675 | 14,815 | D | ||
| Open-market sales · 5,675 sh · avg $146.35 · $830,514 | |||||||
Loading xslF345X05/form4.xml…